mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.097 |
0.07 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.08 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.08 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.08 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.08 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.08 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.08 |